ICF foreign fairs target group diagnostics USA (Q3071751): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Icosagen Cell Factory OÜ commercialises patented technologies through the development and production of antibodies to diagnostic and pharmaceutical companies. In the chosen business model, personal communication with customers not only influences the technological performance of the sales results. The main tool for developing a relationship network in the US diagnostics market and thereby promoting export sales of the service is to present the c...) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
ICF foreign fairs target group diagnostics USA | |||
Revision as of 12:31, 16 August 2021
Project Q3071751 in Estonia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ICF foreign fairs target group diagnostics USA |
Project Q3071751 in Estonia |
Statements
36,740.00 Euro
0 references
73,480.0 Euro
0 references
50.0 percent
0 references
1 August 2019
0 references
31 July 2022
0 references
Icosagen Cell Factory OÜ
0 references
58°22'0.84"N, 26°39'47.41"E
0 references
61713
0 references
Icosagen Cell Factory OÜ kommertsialiseerib patenteeritud tehnoloogiaid läbi antikehade arendamise ja tootmise teenuse osutamise diagnostika- ja farmaatsiaettevõtetele. Valitud ärimudeli puhul mõjutab müügitulemusi tehnoloogilisele võimekusele lisaks ka isiklik suhtlus klientidega. USA diagnostika turul suhtevõrgustiku arendamise ja seeläbi teenuse eksportmüügi edendamise peamiseks vahendiks on ettevõtte esitlemine suurimatel USA diagnostika messidel ja konverentsidel. (Estonian)
0 references
Icosagen Cell Factory OÜ commercialises patented technologies through the development and production of antibodies to diagnostic and pharmaceutical companies. In the chosen business model, personal communication with customers not only influences the technological performance of the sales results. The main tool for developing a relationship network in the US diagnostics market and thereby promoting export sales of the service is to present the company at the largest US diagnostic trade fairs and conferences. (English)
16 August 2021
0 references
Identifiers
2014-2020.5.01.19-1074
0 references